Part 2 of our in-depth discussion about the concept of preclinical RA and steps needed toward a widespread RA prevention framework, with Kevin Deane, MD, PhD.
We spoke with an expert about preclinical RA and steps needed toward a widespread rheumatoid arthritis prevention framework: Vivian P. Bykerk, BSc, MD, FRCPC.